title: Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists.
authors.affiliation: Washington University School of Medicine, St. Louis, MO.
authors.forename: J W
authors.initials: JW
authors.lastname: Olney
authors.forename: M T
authors.initials: MT
authors.lastname: Price
authors.forename: J
authors.initials: J
authors.lastname: Labruyere
authors.forename: K S
authors.initials: KS
authors.lastname: Salles
authors.forename: G
authors.initials: G
authors.lastname: Frierdich
authors.forename: M
authors.initials: M
authors.lastname: Mueller
authors.forename: E
authors.initials: E
authors.lastname: Silverman
mesh_terms: D000978:Antiparkinson Agents / Q000378:metabolism / Q000494:pharmacology*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D001667:Binding, Competitive; D066298:In Vitro Techniques; D016202:N-Methylaspartate; D010622:Phencyclidine / Q000378:metabolism*; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D017478:Receptors, Phencyclidine
chemical_list: D000978:Antiparkinson Agents; D017981:Receptors, Neurotransmitter; D017478:Receptors, Phencyclidine; D001224:Aspartic Acid; D016202:N-Methylaspartate; D010622:Phencyclidine